An evidence-based approach to the evaluation and treatment of premature rupture of membranes: Part II

Obstetrical and Gynecological Survey

Volumn 59, Issue 9, 2004, Pages 678-689

  Canavan, Timothy P ^a   Simhan, Hyagriv N ^a   Caritis, Steve ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CLINDAMYCIN; CORTICOSTEROID; MAGNESIUM SULFATE; MEZLOCILLIN; PENICILLIN G; PIPERACILLIN; PLACEBO; RITODRINE; TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

ADJUVANT THERAPY; AMNIOCENTESIS; CONSERVATIVE TREATMENT; CORTICOSTEROID THERAPY; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; EXERCISE TEST; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; NEWBORN INTENSIVE CARE; OUTCOMES RESEARCH; PREECLAMPSIA; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; REVIEW; SURVIVAL; TOCOLYSIS; UTERINE CERVIX CERCLAGE;

ADRENAL CORTEX HORMONES; ALGORITHMS; ANTI-BACTERIAL AGENTS; EVIDENCE-BASED MEDICINE; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; FETAL MONITORING; GESTATIONAL AGE; HUMANS; LUNG; PREGNANCY; TOCOLYTIC AGENTS;

EID: 4344590921     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ogx.0000137611.26772.2d     Document Type: Review

References (51)

1. Christensen KK, Ingemarsson I, Leideman T, et al. Effect of ritodrine on labor after premature rupture of the membranes. Obstet Gynecol 1980;55:187-190. (Level I)
2. Levy DL, Warsof SL. Oral ritodrine and preterm premature rupture of membranes. Obstet Gynecol 1985;66:621-623. (Level II-1)
3. Weiner CP, Renk K, Klugman M. The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes. Am J Obstet Gynecol 1988;159:216-222. (Level I)
4. How HY, Cook CR, Cook VD, et al. Preterm premature rupture of membranes: aggressive tocolysis versus expectant management. J Matern Fetal Med 1998;7:8-12. (Level I)
5. Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347: 233-239. (Level II-2)
6. Schrag S, Gorwitz R, Fultz-Butts K, et al. Prevention of perinatal group B streptococcal disease. MMWR Morb Mortal Wkly Rep 2002;51(RR 11):1-22. (Level II-2)
7. Mercer B, Miodovnik M, Thurnau G, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: a randomized controlled trial. JAMA 1997;278:989-995. (Level I)
8. Kenyon SL, Taylor DJ, Tarnow-Mordi W, et al. Broad spectrum antibiotics for preterm, prelabor rupture of fetal membranes: the ORACLE I randomized trial. Lancet 2001;357:979-988. (Level I)
9. National Institute of Health. NIH Consensus Development Conference Statement: effect of corticosteroids for fetal lung maturation on perinatal outcomes, February 28-March 2, 1994. Am J Obstet Gynecol 1995;173:246-252. (Level III)
10. Lewis DF, Fontenot MT, Brooks GG, et al. Latency period after preterm premature rupture of membranes: a comparison of ampicillin with and without sulbactam. Obstet Gynecol 1995; 86:392-395. (Level I)
11. Harding JE, Pang J, Knight DB, et al. Do antenatal corticosteroids help in the setting of preterm rupture of membranes. Am J Obstet Gynecol 2001;184:131-139. (metaanalysis)
12. Moberg LJ, Garite TJ, Freeman RK. Fetal heart rate pattems and fetal distress in patients with preterm premature rupture of membranes. Obstet Gynecol 1984;64:60-64. (Level II-2)
13. Harding JA, Jackson DM, Lewis DF, et al. Correlation of amniotic fluid index and nonstress test in patients with preterm premature rupture of membranes. 1991;165:1088-1094. (Level II-3)
14. Hoskins IA, Frieden FJ, Young BK. Variable decelerations in reactive nonstress tests with decreased amniotic fluid index predict fetal compromise. Am J Obstet Gynecol 1991;165: 1094-1098. (Level II-3)
15. Freeman RK, Anderson G, Dorchester W. A prospective multi-institutional study of antenatal fetal heart rate monitoring. I. Risk of perinatal mortality and morbidity according to antenatal fetal heart rate test results. Am J Obstet Gynecol 1982; 143:771-777. (Level II-3)
16. Vintzileos AM, Campbell WA, Nochimson DJ, et al. The use of the nonstress test in patients with premature rupture of the membranes. Am J Obstet Gynecol 1986;155:149-153. (Level I-3)
17. Mercer BM. Preterm premature rupture of membranes. Obstet Gynecol 2003;101:178-193. (Level III)
18. Rib DM, Sherer DM, Woods JR. Maternal and neonatal outcome associated with prolonged premature rupture of membranes below 26 weeks' gestation. Am J Perinatol 1993;10: 369-373. (Level II-3)
19. Nimrod C, Nicholson S, Davies D, et al. Pulmonary hypoplasia in clinical obstetrics. Am J Obstet Gynecol 1988;158:277-280. (Level II-2).
20. Ohlsson A, Fong K, Rose T, et al. Prenatal ultrasonic prediction of autopsy-proven pulmonary hypoplasia. Am J Perinatol 1992;9:334-337. (Level II-2)
21. Assessment of fetal lung maturity. ACOG Educational Bulletin 230. Washington, DC: American College of Obstetricians and Gynecologists; 1996. (Level II-3)
22. Lockitch G, Wittmann BK, Mura SM, et al. Evaluation of the Amniostat-FLM assay for assessment of fetal lung maturity. Clin Chem 1984;30:1233-1237. (Level II-2)
23. Hagen E, Link JC, Arias F. A comparison of the accuracy of the TDx-FLM assay, lecithin-sphingomyelin ratio, and phosphatidylglycerol in the prediction of neonatal respiratory distress syndrome. Obstet Gynecol 1993;82:1004-1008. (Level II-2)
24. Fantz CR, Powell C, Karon B, et al. Assessment of the diagnostic accuracy of the TDx-FLM II to predict fetal lung maturity. Clin Chem 2002;48:761-765. (Level II-3)
25. Carlan SJ, O'Brien WF, Parsons MT, et al. Preterm premature rupture of membranes: a randomized study of home versus hospital management. Obstet Gynecol 1993;81:61-64. (Level I)
26. Premature rupture of membranes. ACOG Practice Bulletin no. 1. Washington, DC: American College Obstetricians and Gynecologists; 1998. (Level III)
27. Ludmir J, Bader T, Chen L, et al. Poor perinatal outcome associated with retained cerclage in patients with premature rupture of membranes. Obstet Gynecol 1994;84:823-826. (Level II-2)
28. Yeast JD, Garite TR. The role of cervical cerclage in the management of preterm premature rupture of membranes. Am J Obstet Gynecol 1988;158:106-110. (Level II-3)
29. Jenkins TM, Berghella V, Shlossman PA, et al. Timing of cerclage removal after preterm premature rupture of membranes: maternal and neonatal outcomes. Am J Obstet Gynecol 2000;163:847-852. (Level II-2)
30. McElrath TF, Norwitz ER, Lieberman, et al. Management of cervical cerclage and preterm premature rupture of the membranes: should the stitch be removed. Am J Obstet Gynecol 2000;183:840-846. (Level II-2)
31. Ananth CV, Savitz DA, Williams MA. Placental abruption and its association with hypertension and prolonged rupture of membranes: a methodologic review and meta-analysis. Obstet Gynecol 1996;88:309-318. (metaanalysis)
32. Ovalle-Salas A, Gomez R, Martinez MA, et al. Antibiotic therapy in patients with preterm premature rupture of membranes: a prospective, randomized, placebo-controlled study with microbiological assessment of the amniotic cavity and lower genital tract. Prenat Neonat Med 1997;2:213-222. (Level I)
33. Lovett SM, Weiss JD, Diogo MJ, et al. A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy. Am J Obstet Gynecol 1997;176:1030-1038. (Level I)
34. Lockwood CJ, Costigan K, Ghidini A, et al. Double-blind, placebo-controlled trial of piperacillin prophylaxis in preterm membrane rupture. Am J Obstet Gynecol 1993;169:970-976. (Level I)
35. Johnston MM, Sanchez-Ramos L, Vaughn AJ, et al. Antibiotic therapy in preterm premature rupture of membranes: a randomized, prospective, double-blind trial. Am J Obstet Gynecol 1990;163:743-747. (Level I)
36. Dinsmoor MJ, Bachman R, Haney EI, et al. Outcomes after expectant management of extremely preterm premature rupture rupture of the membranes. Am J Obstet Gynecol 2004; 190:183-187. (Level II-3)
37. Morales WJ, Talley. Premature rupture of membranes at <25 weeks: a management dilemma. Am J Obstet Gynecol 1993; 168:503-507. (Level II-2)
38. Major CA, Kitzmiller JL. Perinatal survival with the expectant management of midtrimester rupture of membranes. Am J Obstet Gynecol 1990;163:838-844. (Level II-2)
39. Bengtson JM, VanMarter LJ, Barass VA, et al. Pregnancy outcome after premature rupture of the membranes at or before 26 weeks' gestation. Obstet Gynecol 1989;73:921-926. (Level II-2)
40. Moretti M, Sibai BM. Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester. Am J Obstet Gynecol 1988;159:390-396. (Level II-2)
41. Taylor J, Garite TJ. Premature rupture of membranes before fetal viability. Obstet Gynecol 1984;64:615-620. (level II-2)
42. Fong K, Ohlsson A, Zalev A. Fetal thoracic circumference: a prospective cross sectional study with real-time ultrasound. Am J Obstet Gynecol 1988;158:1154-1160. (Level II-2)
43. Sonster GS, Gray DL, Crane JP. Prenatal prediction of lethal pulmonary hypoplasia using ultrasonic fetal chest circumference. Obstet Gynecol 1989;73:261-266. (Level II-3)
44. Vintzileos AM, Campbell WA, Rodis JF, et al. Comparison of six different ultrasonographic methods for predicting lethal pulmonary hypoplasia. Am J Obstet Gynecol 1989;161:606-612. (Level II-2)
45. van Eyck J, van der Mooren K, Wladimiroff JW. Ductus arteriosus flow velocity modulation by fetal breathing movements as a measure of fetal lung development. Am J Obstet Gynecol 1990;163:558-566. (Level II-1)
46. Roberts AB, Mitchell JM. Direct ultrasonographic measurement of fetal lung length in normal pregnancies and pregnancies complicated by prolonged rupture of membranes. Am J Obstet Gynecol 1990;163:1560-1566. (Level II-2)
47. D'Alton M, Mercer B, Riddick E, et al. Serial thoracic versus abdominal circumference ratios for the prediction of pulmonary hypoplasia in premature rupture of the membranes remote from term. Am J Obstet Gynecol 1992;166:658-663. (Level II-2)
48. Fox HE, Badalian SS, Timor-Tritsch IE, et al. Fetal upper respiratory tract function in cases of antenatally diagnosed congenital diaphragmatic hernia: preliminary observations. Ultrasound Obstet Gynecol 1993;3:164-167. (Level II-3)
49. Naef RW, Allbert JR, Ross EL, et al. Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. Am J Obstet Gynecol 1998;178:126-130. (Level I)
50. Cox SM, Leveno KJ. Intentional delivery versus expectant management with preterm ruptured membranes at 30-34 weeks' gestation. Obstet Gynecol 1995;86:875-879. (Level I)
51. Mercer BM, Crocker LG, Boe NM, et al. Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. Am J Obstet Gynecol 1993;169:775-782. (Level I)